Antiretroviral Combination Might Increase Bradycardia Risk in Elderly, Critically Ill COVID-19 Patients

News

Antiretroviral Combination Might Increase Bradycardia Risk in Elderly, Critically Ill COVID-19 Patients

Posted: 07/09/2020
Author:
Jason Wermers, CRTonline.org

A combination of antiretroviral medications might increase the risk of bradycardia in elderly patients with severe COVID-19, according to a small study that was published Thursday.

Most Viewed Pages

TARGET BP I: Alcohol-Mediated RDN Shows ‘Modest but Significant’ 24-Hour Ambulatory Systolic BP Drop vs. Sham Procedure at 3 Months

Coronary Sinus Reducer Relieves Angina, but Mechanism Remains Unclear: ORBITA-COSMIC Trial

TAVR Noninferior to SAVR for All-Cause Mortality, Stroke at 1 Year in Low- to Intermediate-Risk Patients: DEDICATE

The DanGer Shock Trial & Panel Discussion

Web App Proves Effective in Aiding Patients’ Self-Selection for OTC Rosuvastatin: TACTiC Trial

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

News

Antiretroviral Combination Might Increase Bradycardia Risk in Elderly, Critically Ill COVID-19 Patients

Most Viewed Pages

Explore the Site

Stay Connected